National Association of Testing Authorities, Australia
Scope of Accreditation
4Cyte Pathology Pty Ltd
Site
4Cyte Pathology Sydney
Accreditation No.
20341
Site No.
24317
Date of Accreditation
18 Jul 2018
Contact
Ms Shannon Carrick P: +61 (02) 86468726
Availability
Services available to external clients
Supervision
GX (General)
Scope of Accreditation
Biochemistry
ISO 15189 (2022)
Human Pathology
Medicare expiry date
04 Nov 2026
Last Activity Date
24 Feb 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Urine | 3,4-Methylenedioxymethamphetamine (MDMA); Amphetamines; Benzodiazepines; Buprenorphine; Cannabis; Cocaine; Ethanol; Methadone metabolites; Opiates |
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Serum | Digoxin |
| Carbamazepine; Digoxin; Lithium; Phenytoin (dilantin); Valproate (valproic acid, epilim) | ||
| Chemical pathology - Detection and/or quantitation of tumour markers | Serum | β2-Microglobulin (B2M) |
| Prostate specific antigen (PSA); Prostate specific antigen (PSA) fractions and derived index | ||
| Thyroglobulin | ||
| Human chorionic gonadotropin (hCG); Prostate specific antigen (PSA) | ||
| CA125 antigen (CA125); CA15-3 antigen (CA15-3); CA19-9 antigen (CA19-9); Carcinoembryonic antigen (CEA); α-Fetoprotein (AFP) | ||
| Chemical pathology - Detection of faecal occult blood | Faeces | Blood |
| Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Plasma | Parathyroid hormone (PTH) |
| Adrenocorticotropic hormone (ACTH) | ||
| Plasma; Serum | Aldosterone; Renin | |
| Serum | Androstenedione; Growth hormone; Insulin-like growth factor 1 (IGF-1, somatomedin C) | |
| C-peptide; Cortisol; Dehydroepiandrosterone sulfate (DHEAS); Follicle stimulating hormone (FSH); Insulin; Luteinising hormone (LH); Oestradiol; Progesterone; Prolactin; Sex hormone binding globulin (SHBG); Testosterone | ||
| Anti-Mullerian hormone (AMH) | ||
| Chemical pathology - Diagnosis and management of diabetes mellitus | Plasma | Glycated haemoglobin (HbA1c) |
| Serum | Fructosamine | |
| Chemical pathology - Further investigation of cardiac function | Serum | Troponin I |
| N-Terminal-pro b-type natriuretic peptide (NT-proBNP) | ||
| Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia | Plasma; Serum | Lipoprotein a |
| Serum | Apolipoprotein A; Apolipoprotein B; HDL - Quantitation | |
| Chemical pathology - Further investigation of renal and/or hepatic function | Serum | Caeruloplasmin; Haptoglobins |
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Plasma; Serum; Urine | Glucose |
| Serum | Calcium - Ionised | |
| Alanine aminotransferase; Alkaline phosphatase; Aspartate aminotransferase; Bicarbonate; Bilirubin - Any fractions; C-reactive protein (CRP); Cholesterol - LDL; Cholesterol - Total; Creatine kinase; Lactate dehydrogenase (LDH); Lipase; Triglycerides; γ-Glutamyltransferase | ||
| Serum; Urine | Osmolality | |
| Albumin; Calcium - Total; Chloride; Creatinine; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Urate; Urea | ||
| Urine | Microalbumin | |
| Chemical pathology - Investigation for folate deficiency | Serum | Folate |
| Chemical pathology - Investigation of maternal markers to detect foetal abnormality | Serum | Free β-human chorionic gonadotropin (free β-hCG); Pregnancy associated plasma protein A (PAPP-A) |
| Chemical pathology - Iron studies | Serum | Iron; Transferrin |
| Ferritin | ||
| Chemical pathology - Quantitation of precursor and intermediary metabolites | Plasma | Homocysteine |
| Chemical pathology - Quantitation of vitamin B markers | Serum | Holotranscobalamin (active vitamin B12) |
| Chemical pathology - Quantitation of vitamins | Serum | Cobalamin (vitamin B12); Vitamin D |
| Chemical pathology - Tests for thyroid function | Serum | Thyroid stimulating hormone (TSH); Thyroxine (T4) - Free; Triiodothyronine (T3) - Free |
| Chemical pathology - Trace element analysis | Serum | Copper; Zinc |
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Serum | Anti-thyroid stimulation immunoglobulin antibodies (TSI) |
| Anti-thyroglobulin antibodies (Tg); Anti-thyroid peroxidase antibodies (TPO) | ||
| Immunopathology - Quantitation of complement proteins | Serum | Complement components C3 and C4 |
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Faeces | Calprotectin |
| Serum | α1-Antitrypsin phenotype | |
| Urine | Detection of Bence Jones proteins | |
| Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses | Serum | Total immunoglobulin A; Total immunoglobulin G; Total immunoglobulin M |
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis or follow up of threatened abortion and/or diagnosis of ectopic pregnancy | Serum | Human chorionic gonadotropin (hCG) - Quantitative total |
Cytopathology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
04 Nov 2026
Last Activity Date
24 Feb 2024
| Service | Product | Determinant |
|---|---|---|
| Anatomical pathology - Cytopathology - Cervical cytological investigation for abnormalities, precancerous or cancerous changes or conditions | Cervical smear; Liquid based cytology specimens from cervix | Human papilloma virus cytological examination; Cytological examination; Review and reporting of cervical cytological material |
| Anatomical pathology - Cytopathology - Gynaecological (non-cervical) cytological investigation for abnormalities, precancerous or cancerous changes or conditions | Endometrial pipelle; Liquid based cytology specimens from cervix; Vaginal smears; Vault smears; Vulval smears | Cytological examination; Review and reporting of gynaecological (non-cervical tissue) cytological samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of body fluids, exudates, washings and brushings from non-squamous mucosal sites for the detection of malignancy | Urine | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Cytopathology - Testing for the National Cervical Screening Program | Liquid based cytology specimens from cervix; Liquid based cytology specimens from vaginal vault | Human papilloma virus (HPV); Cytological examination; Review and reporting of cervical cytological material |
| Self-collected vaginal swabs | Human papilloma virus (HPV) |
Haematology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
04 Nov 2026
Last Activity Date
24 Feb 2024
| Service | Product | Determinant |
|---|---|---|
| Haematology - Bone marrow examination | Bone marrow; Trephine | Examination of aspirated material; Histological examination |
| Examination of aspirated material; Histological examination | ||
| Haematology - Diagnosis of thalassemia | Blood | Examination of haemoglobin H (HbH); Haemoglobin A (HbA) - Quantitation; Haemoglobin A2 (HbA2) - Quantitation; Haemoglobin F (HbF) - Quantitation; Haemoglobin H (HbH) inclusions |
| Haematology - Examination of blood films by special staining | Blood | Malaria |
| Haematology - Full blood examination | Blood | Morphology |
| Morphology | ||
| Differential number; Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Mean platelet volume (MPV); Nucleated red blood cells (NRBC); Platelet count; Red blood cell distribution width (RDW); Red blood cell index or indices; Reticulocytes | ||
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Plasma | Anti-thrombin III; Factor II; Factor IX; Factor VII; Factor VIII; Factor X; Factor XI; Factor XII; Factor XIII deficiency; Lupus anticoagulant; Protein C and protein S; Von Willebrand factor (vWF) activity - VWF:GPIbM; Von Willebrand factor (vWF) antigen - Quantitation |
| Activated partial thromboplastin time (APTT); D-dimer; Fibrinogen; International normalised ratio (INR); Prothrombin time (PT); Thrombin time (TT) | ||
| Haematology - Investigation of haemoglobinopathy (excluding thalassemia) | Blood | Haemoglobin S (HbS) - Presence; Haemoglobin fraction (S, C, D, E) - Quantitation; Other abnormal haemoglobins |
| Haematology - Limited blood examination | Blood | Erythrocyte (RBC) sedimentation rate (ESR) |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Blood | Malaria |
Human Genetics
ISO 15189 (2022)
Human Pathology
Medicare expiry date
04 Nov 2026
Last Activity Date
24 Feb 2024
| Service | Product | Determinant |
|---|---|---|
| Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted genes | Blood | Factor V Leiden; Prothrombin variant |
| Extracted DNA | Haemochromatosis | |
| HLA-B27 | ||
| Coeliac disease | ||
| Molecular genetics - DNA extraction | Blood | Purified PCR product; Quantification of DNA; Sample assessment and identification; Viable DNA |
| Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted genes | Extracted DNA | JAK2 V617F mutation |
Immunohaematology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
04 Nov 2026
Last Activity Date
24 Feb 2024
| Service | Product | Determinant |
|---|---|---|
| Immunohaematology - Blood group antibody detection | Plasma | Duffy system; Kell system; M and N factors; Other blood group systems; Rh phenotypes |
| Immunohaematology - Blood grouping | Blood; Plasma | ABO; RhD |
| ABO; RhD | ||
| Immunohaematology - Identification and quantitation of blood group antibodies | Blood | Red blood cell phenotyping |
| Red blood cell phenotyping | ||
| Direct antiglobulin test (DAT, direct Coombs test) | ||
| Plasma | Other blood group antibodies; Rh | |
| Antibody titration | ||
| Other blood group antibodies; Rh |
Immunology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
04 Nov 2026
Last Activity Date
24 Feb 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Further investigation of renal and/or hepatic function | Serum | Tryptase |
| Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping) | Blood | CD16; CD19; CD21; CD24; CD27; CD3; CD38; CD4; CD56; CD8; Immunoglobulin D (IgD); Immunoglobulin M (IgM); Natural killer (NK) cells |
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Serum | Anti-cardiolipin antibodies (ACA); Anti-cyclic citrullinated peptide antibodies (CCP); Anti-deamidated gliadin antibodies; Anti-double stranded DNA antibodies (dsDNA); Anti-extractable nuclear antigen antibodies (ENA); Anti-gastric parietal cell antibodies (GPC/PCA); Anti-glomerular basement membrane antibodies (anti-GBM); Anti-intrinsic factor antibodies (IF); Anti-myeloperoxidase antibodies (MPO); Anti-proteinase 3 antibodies (PR3); Anti-tissue transglutaminase antibodies (tTG) |
| Rheumatoid factor | ||
| Anti-endomysial antibodies (EMA); Anti-liver-kidney microsomes antibodies (LKM); Anti-mitochondrial antibodies (AMA, AMA M1 and/or AMA M2); Anti-neutrophil cytoplasmic antibodies (ANCA); Anti-nuclear antibodies (ANA); Anti-smooth muscle antibodies (SMA) | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential epidermal and animal protein allergens) | Serum | Animal mix; Cat dander; Dog dander; Guinea pig epithelium; Rabbit epithelium |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [egg and fowl] allergens) | Serum | Chicken; Egg; Egg white |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [fish, shellfish and molluscs] allergens) | Serum | Codfish; Crab; Lobster; Prawn |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [fruit and vegetable] allergens) | Serum | Banana; Fruit mix; Kiwi; Melon |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [meat] allergens) | Serum | Beef; Mutton; Pork |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [milk] allergens) | Serum | Milk |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [miscellaneous] allergens) | Serum | Staple food mix |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [seeds, legumes and nuts] allergens) | Serum | Almond; Brazil nut; Coconut; Hazelnut; Nut panel; Oat; Peanut; Rice; Rye; Soy bean |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential grass pollen allergens) | Serum | Grass mix |
| Bermuda grass; Meadow fescue; Paspalum grass; Rye grass | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential microorganism allergens) | Serum | Alternaria alternata; Aspergillus fumigatus; Cladosporium herbarum; Mould mix |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential mite allergens) | Serum | Dermatophagoides pteronyssinus house dust mite |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential occupational allergens) | Serum | Latex |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential tree pollen allergens) | Serum | Acacia; Olive; Silver birch |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential venom allergens) | Serum | Bumblebee venom; Common wasp (yellow jacket) venom; European paper wasp venom |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential weed pollen allergens) | Serum | Plantain - English; Weed mix |
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Serum | Detection and quantitation of free kappa and free lambda light chains |
| α1-Globulin; α2-Globulin; β-Globulin; γ-Globulin | ||
| Detection and amount of paraproteins; Immunoglobulin A (IgA) - Kappa; Immunoglobulin A (IgA) - Lambda; Immunoglobulin G (IgG) - Kappa; Immunoglobulin G (IgG) - Lambda; Immunoglobulin M (IgM) - Kappa; Immunoglobulin M (IgM) - Lambda; Monoclonal proteins; α1-Globulin; α2-Globulin; β-Globulin; γ-Globulin | ||
| Urine | Detection of Bence Jones proteins | |
| Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses | Serum | Immunoglobulin subclasses |
| Total immunoglobulin E |
Microbiology
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
04 Nov 2026
Last Activity Date
24 Feb 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Investigation of Helicobacter pylori colonisation or eradication | Breath | C14 |
| Infertility and pregnancy tests including assisted reproductive technology - Semen analysis (other than post vasectomy) | Semen | Morphology |
| Colour; Viscosity | ||
| Volume | ||
| Agglutination; Morphology; Motility; Sperm number | ||
| pH | ||
| Infertility and pregnancy tests including assisted reproductive technology - Semen analysis for post vasectomy and/or examination of cervical mucus | Semen | Presence of spermatozoa |
| Microbiology - Bacteriology - Detection and identification of crystalline material | Synovial fluid | Crystal detection and identification |
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Aspirates; Biopsy specimens; Blood; Bronchoalveolar lavage; Bronchoalveolar washings; Cerebrospinal fluid (CSF); Ear swabs; Eye swabs; Faeces; Fluids; General swabs; Genital swabs; Intra-uterine contraceptive device (IUCD); Nasal swabs; Operative specimens; Post-operative wounds; Pus; Respiratory specimens; Semen; Skin; Throat swabs; Tissues; Urine; Wound swabs | Pathogenic identification and antibiotic susceptibility |
| Pathogenic microorganisms | ||
| Aspirates; Biopsy specimens; Blood; Bronchoalveolar lavage; Bronchoalveolar washings; Cerebrospinal fluid (CSF); Ear swabs; Eye swabs; Fluids; General swabs; Genital swabs; Nasal swabs; Operative specimens; Post-operative wounds; Pus; Respiratory specimens; Semen; Skin; Throat swabs; Tissues; Urine; Wound swabs | Staphylococcus aureus | |
| Aspirates; Biopsy specimens; Bronchoalveolar lavage; Bronchoalveolar washings; Cerebrospinal fluid (CSF); Ear swabs; Eye swabs; Faeces; Fluids; General swabs; Genital swabs; Intra-uterine contraceptive device (IUCD); Nasal swabs; Operative specimens; Post-operative wounds; Pus; Respiratory specimens; Semen; Skin; Throat swabs; Tissues; Wound swabs | Pathogenic identification and antibiotic susceptibility | |
| Blood | Bacteria; Pathogenic microorganisms | |
| Cervical swabs; Eye swabs; Genital specimens; Genital swabs; Intra-uterine contraceptive device (IUCD); Joint fluid; Nasopharyngeal aspirate; Nasopharyngeal swabs; Ocular specimens; Oral sites; Rectal swabs; Semen; Synovial fluid; Throat swabs; Urethra; Urine; Vaginal swabs | Neisseria gonorrhoeae; Pathogenic identification and antibiotic susceptibility | |
| Genital swabs | Streptococcus spp. | |
| Streptococcus group B screening | ||
| Urine | Bacteria; Blood; Casts; Crystals; Epithelial cells; Erythrocytes (red blood cells, RBC); Glucose; Haemoglobin (Hb); Ketones; Leucocytes (white blood cells, WBC); Proteins; pH | |
| Pathogenic identification and antibiotic susceptibility | ||
| Microbiology - Mycobacteriology - Tests for cell mediated immunity | Blood | Interferon-γ (IFN-γ) release assays; Latent tuberculosis |
| Microbiology - Mycology - Detection of dermatophytes and other fungi causing cutaneous disease | Hair; Nails; Skin scrapings | Dermatophyte identification |
| Microbiology - Mycology - Detection, isolation and/or identification of yeasts and/or fungal elements | Aspirates; Blood; Bronchial lavage; Bronchial washings; Cerebrospinal fluid (CSF); Ear swabs; Eye swabs; Faeces; Fluids; General swabs; Genital swabs; Intra-uterine contraceptive device (IUCD); Nasal swabs; Operative specimens; Post-operative wounds; Pus; Respiratory specimens; Serum; Skin; Throat swabs; Tissues; Urine; Wound swabs | Yeasts identification |
| Aspirates; Blood; Bronchial lavage; Bronchial washings; Cerebrospinal fluid (CSF); Ear swabs; Eye swabs; Fluids; Genital swabs; Hair; Nails; Nasal swabs; Ocular specimens; Operative specimens; Post-operative wounds; Respiratory swabs; Skin; Skin scrapings; Sputum; Throat swabs; Tissues; Urine; Wound swabs | Fungi identification; Yeasts identification | |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Faeces | Cryptosporidia; Cyclospora; Giardia spp.; Microsporidia; Schistosoma spp.; Strongyloides stercoralis; Cysts; Ova; Parasites; Worms |
| Cryptosporidia; Cyclospora; Giardia spp.; Microsporidia; Schistosoma spp.; Strongyloides stercoralis; Cysts; Ova; Parasites; Worms | ||
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Faeces | Helicobacter pylori |
| Plasma; Serum | Bordetella pertussis IgA; Bordetella pertussis IgG; Epstein-Barr virus IgG antibody; Epstein-Barr virus IgM antibody; Epstein-Barr virus nuclear antigen; Hepatitis B virus core antibody (anti-HBc) - Total; Hepatitis C virus antibody (anti-HCV); Hepatitis C virus antibody (anti-HCV) - Total; Herpes simplex virus type 1 antibody (anti-HSV1) - IgM; Herpes simplex virus type 2 antibody (anti-HSV2) - IgG; Herpes simplex virus type 2 antibody (anti-HSV2) - IgM; Herpes simplex type 1 antibody (anti-HSV1) - IgG; Measles IgG antibody; Measles IgM antibody; Mumps virus IgG antibody; Mumps virus IgM antibody; Mycoplasma pneumoniae IgG antibody; Mycoplasma pneumoniae IgM antibody; Parvovirus IgG antibody; Parvovirus IgM antibody; Varicella zoster virus (VZV) IgG antibody; Varicella zoster virus IgM antibody | |
| Hepatitis A virus antibody (anti-HAV) - IgM; Hepatitis A virus antibody (anti-HAV) - Total; Hepatitis B virus core antibody (anti-HBc) - IgM; Hepatitis B virus envelope antibody (anti-HBe); Hepatitis B virus envelope antigen (HBe Ag); Hepatitis B virus surface antibody (anti-HBs); Hepatitis B virus surface antigen (HBs Ag); Hepatitis B virus surface antigen (HBs Ag) - Confirmatory; Hepatitis C virus antibody (anti-HCV); Human immunodeficiency virus type 1/2 (HIV-1/2) 1/2 antibodies; Human immunodeficiency virus type 1/2 (HIV-1/2) antigen; Rubella IgG antibody; Rubella IgM antibody; Syphilis Treponema pallidum antibody; Toxoplasma spp. IgG antibody; Toxoplasma spp. IgM antibody | ||
| Serum | Anti-streptolysin O (ASOT) | |
| Cytomegalovirus antibody (anti-CMV) IgG; Cytomegalovirus antibody (anti-CMV) IgM |
Molecular Biology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
04 Nov 2026
Last Activity Date
24 Feb 2024
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Anal swab; Throat swabs | Chlamydia trachomatis; Neisseria gonorrhoeae |
| Bronchoalveolar lavage; Nasopharyngeal aspirate; Nasopharyngeal swabs; Sputum | Bordetella parapertussis; Bordetella pertussis; Chlamydophila pneumoniae; Legionella pneumophila; Mycoplasma pneumoniae | |
| Cervical swabs; Liquid based cytology specimens; Urethral swabs; Urine; Vaginal swabs | Azithromycin resistant Mycoplasma genitalium | |
| Chlamydia trachomatis; Mycoplasma genitalium; Mycoplasma hominis; Neisseria gonorrhoeae; Ureaplasma urealyticum | ||
| Eye swabs; Mouth swabs; Skin swabs; Throat swabs | Treponema pallidum | |
| Faeces | Aeromonas spp.; Campylobacter spp.; Clostridium difficile toxin B; Escherichia coli - Enteroinvasive (EIEC); Salmonella spp.; Shigella spp.; Vibrio spp.; Yersinia enterocolitica | |
| Genital swabs; Liquid based cytology specimens | Chlamydia trachomatis serovars L1, L2, L2a or L3 (LGV); Haemophilus ducreyi; Lymphogranuloma venereum; Treponema pallidum | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (fungi) | Nails | Candida spp.; Trichophyton mentagrophytes; Trichophyton rubrum |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites) | Cervical swabs; Liquid based cytology specimens; Urethral swabs; Urine; Vaginal swabs | Trichomonas vaginalis |
| Faeces | Blastocystis hominis; Cryptosporidium spp.; Cyclospora cayetanensis; Dientamoeba fragilis; Entamoeba histolytica; Giardia lamblia | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Cervical specimen; Liquid based cytology specimens | Human papilloma virus (HPV) |
| Cutaneous swabs; Vesicle swabs | Enterovirus | |
| Eye swabs | Adenovirus | |
| Eye swabs; Lip swabs; Mouth swabs; Skin swabs; Throat swabs | Herpes simplex virus type 1 (HSV1); Herpes simplex virus type 2 (HSV2); Varicella zoster virus (VZV) | |
| Eye swabs; Mouth swabs; Throat swabs | Enterovirus | |
| Faeces | Adenovirus; Astrovirus; Norovirus G1; Norovirus G2; Rotavirus A; Sapovirus | |
| Genital swabs; Liquid based cytology specimens | Herpes simplex virus (HSV); Varicella zoster virus (VZV) | |
| Nasopharyngeal and throat swab; Nasopharyngeal swabs; Oropharyngeal swabs | Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Nasopharyngeal and throat swab; Nasopharyngeal swabs; Throat swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Nasopharyngeal swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Adenovirus; Human metapneumovirus; Influenza A virus; Influenza B virus; Parainfluenza virus; Respiratory syncytial virus (RSV); Rhinovirus | ||
| Nasopharyngeal swabs; Oropharyngeal swabs; Throat swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Nasopharyngeal swabs; Throat swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Adenovirus; Human metapneumovirus; Influenza A virus; Influenza B virus; Parainfluenza virus; Respiratory syncytial virus (RSV); Rhinovirus; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Plasma; Serum | Hepatitis B virus (HBV) viral load; Hepatitis C virus (HCV) viral load; Human immunodeficiency virus (HIV) viral load | |
| Self-collected vaginal swabs | Human papilloma virus (HPV) | |
| Throat swabs | Epstein-Barr virus |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
20341
Site No.
24317
Print date
23 Nov 2024
END OF SCOPE